Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

10.9K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
10.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

801
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
801

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations for assessment of twilight vision and glare sensitivity for safe driving].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2013
Same author

[Letter].

Klinische Monatsblatter fur Augenheilkunde·2013
Same author

[Pitfalls in the determination of distance glasses].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2011
Same author

[Position of the German Society of Ophthalmology and BVA on the change in automobile driving licensure December 2010].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2011
Same author

[Traffic ophthalmology. Assessment of ability to drive in road traffic].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2006
Same author

[Visual field and road traffic. How does peripheral vision function?].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2005
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K

[Traffic Aspects in Glaucoma Patients].

B Lachenmayr1

  • 1Glaukomdiagnostik und Glaukomtherapie, Praxisklinik und Ambulanter OP, München.

Klinische Monatsblatter Fur Augenheilkunde
|February 16, 2016
PubMed
Summary
This summary is machine-generated.

Glaucoma can cause vision loss impacting driving ability. While some vision deficits can be managed, central and horizontal visual field loss due to glaucoma cannot be compensated for, potentially ending driving privileges.

More Related Videos

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

4.4K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

4.4K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Optometry

Background:

  • Glaucoma is a progressive optic neuropathy characterized by morphological and functional deficits.
  • These deficits can lead to binocular visual field defects, impacting daily activities.
  • Specific visual field areas crucial for driving are particularly vulnerable.

Purpose of the Study:

  • To evaluate the impact of glaucomatous damage on driving ability.
  • To identify specific visual field deficits that preclude driving.
  • To explore compensatory strategies for visual impairments in glaucoma patients.

Main Methods:

  • Review of glaucomatous visual field deficits and their functional implications.
  • Analysis of the impact of mesopic vision and glare sensitivity on driving.
  • Assessment of the potential for compensation for various visual field defects.

Main Results:

  • Glaucomatous damage can cause significant visual field defects, especially in central and horizontal areas.
  • Impaired mesopic vision and glare sensitivity are common in glaucoma patients.
  • Binocular visual field defects in critical driving areas are not compensable.

Conclusions:

  • Glaucoma patients with specific visual field deficits may be unfit to drive.
  • Awareness and compensatory strategies are vital for managing glaucoma-related visual impairments.
  • Uncompensated binocular visual field defects in driving-relevant areas necessitate driving cessation.